icon-folder.gif   Conference Reports for NATAP  
 
  HIV R4P
Jan & 27 - 28
Feb 3 & 4 - 2021
Back grey_arrow_rt.gif
 
 
 
Impact of UGT Induction by Rifampin and Rifabutin on Cabotegravir Long-Acting Pharmacokinetics for HIV Pre-exposure Prophylaxis (PrEP) using Population Pharmacokinetic Modeling and Simulation
 
 
  HIVR4P 2021 (Virtual event); 27-28 January & 3-4 February 2021
Reported by Jules Levin
 
Kelong Han, 1 Mark Baker, 2 David Margolis, 2 William Spreen, 2 Susan L. Ford 3 1GlaxoSmithKline, Collegeville, PA; 2ViiV Healthcare, Research Triangle Park, NC; 3GlaxoSmithKline, Research Triangle Park, NC

0128211

0128212

0128213

0128214

0128215